CBIO·G2545C104·US·equity·Healthcare - Biotechnology-Activist
CBIO (CRESCENT BIOPHARMA INC.) is held by 33 institutional investors as of Q1 2026. Largest holders: FMR LLC ($75.9M), BALYASNY ASSET MANAGEMENT L.P. ($27.7M), RTW INVESTMENTS, LP ($6.8M). Net institutional sentiment: Mixed.
See how CBIO's score breaks down across 4 SEC sources
Showing 1-20 of 41
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer